S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY. (31st January 2022) - Marktel, S; Scaramuzza, S; Giglio, F; Cicalese, M; Lidonnici, M; Rossi, C; Calbi, V; Masera, N; D'Angelo, E; Mirra, N; Origa, R; Tartaglione, I; et al.